SG149826A1 - Method for improved breast milk feeding to reduce the risk of allergy - Google Patents
Method for improved breast milk feeding to reduce the risk of allergyInfo
- Publication number
- SG149826A1 SG149826A1 SG200900212-2A SG2009002122A SG149826A1 SG 149826 A1 SG149826 A1 SG 149826A1 SG 2009002122 A SG2009002122 A SG 2009002122A SG 149826 A1 SG149826 A1 SG 149826A1
- Authority
- SG
- Singapore
- Prior art keywords
- allergy
- risk
- reduce
- breast milk
- milk feeding
- Prior art date
Links
- 206010020751 Hypersensitivity Diseases 0.000 title abstract 2
- 208000026935 allergic disease Diseases 0.000 title abstract 2
- 230000007815 allergy Effects 0.000 title abstract 2
- 210000004251 human milk Anatomy 0.000 title abstract 2
- 235000020256 human milk Nutrition 0.000 title abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/025—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
- G01N33/6869—Interleukin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/173—Reuteri
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/335—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Lactobacillus (G)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/475—Assays involving growth factors
- G01N2333/495—Transforming growth factor [TGF]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Mycology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Epidemiology (AREA)
- Wood Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Zoology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Biophysics (AREA)
- Endocrinology (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/860,201 US7955834B2 (en) | 2004-06-03 | 2004-06-03 | Method for improved breast milk feeding to reduce the risk of allergy |
| PCT/SE2005/000806 WO2005117532A2 (en) | 2004-06-03 | 2005-05-30 | Method for improved breast milk feeding to reduce the risk of allergy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG149826A1 true SG149826A1 (en) | 2009-02-27 |
Family
ID=35449179
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG200900212-2A SG149826A1 (en) | 2004-06-03 | 2005-05-30 | Method for improved breast milk feeding to reduce the risk of allergy |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US7955834B2 (sl) |
| EP (3) | EP1994936A1 (sl) |
| KR (2) | KR20080034212A (sl) |
| CN (3) | CN102334561A (sl) |
| AU (2) | AU2005249338B2 (sl) |
| BR (1) | BRPI0510198A (sl) |
| CA (2) | CA2560472C (sl) |
| DK (1) | DK3061458T3 (sl) |
| ES (1) | ES2639827T3 (sl) |
| HK (2) | HK1100508A1 (sl) |
| IL (2) | IL178686A (sl) |
| LT (1) | LT3061458T (sl) |
| NO (1) | NO341456B1 (sl) |
| NZ (2) | NZ550527A (sl) |
| RU (1) | RU2385730C2 (sl) |
| SG (1) | SG149826A1 (sl) |
| SI (1) | SI3061458T1 (sl) |
| WO (1) | WO2005117532A2 (sl) |
| ZA (2) | ZA200608914B (sl) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060251634A1 (en) * | 2005-05-06 | 2006-11-09 | Ho-Jin Kang | Method of improving immune function in mammals using lactobacillus strains with certain lipids |
| US8287931B2 (en) * | 2005-06-30 | 2012-10-16 | Mead Johnson Nutrition Company | Nutritional composition to promote healthy development and growth |
| US8075934B2 (en) * | 2008-10-24 | 2011-12-13 | Mead Johnson Nutrition Company | Nutritional composition with improved digestibility |
| US7374924B2 (en) * | 2006-06-05 | 2008-05-20 | Biogaia Ab | Use of selected lactic acid bacteria for reducing infantile colic |
| EP1997499A1 (en) * | 2007-05-31 | 2008-12-03 | Puleva Biotech, S.A. | Mammalian milk microorganisms, compositions containing them and their use for the treatment of mastitis |
| FI121952B (fi) | 2009-05-06 | 2011-06-30 | Oriola Oy | Menetelmä pisaroina annosteltavan terveystuotteen valmistamiseksi |
| US8293264B2 (en) * | 2009-05-11 | 2012-10-23 | Mead Johnson Nutrition Company | Nutritional composition to promote healthy development and growth |
| US8785183B2 (en) * | 2010-09-21 | 2014-07-22 | Biogaia Ab | Active plastic material in oil |
| JP2012092094A (ja) * | 2010-09-30 | 2012-05-17 | Wakamoto Pharmaceutical Co Ltd | 油脂中に乳酸菌を含有する口腔用組成物 |
| MX352040B (es) | 2010-12-31 | 2017-11-07 | Abbott Lab | Formulaciones nutricionales que incluyen los oligosacaridos de leche humana y los acidos grasos poliinsaturados de cadena larga y usos de las mismas. |
| EP3510873A1 (en) | 2010-12-31 | 2019-07-17 | Abbott Laboratories | Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection |
| CN110051676A (zh) * | 2010-12-31 | 2019-07-26 | 雅培制药有限公司 | 用于调节炎症的人乳寡糖 |
| EP3473257A1 (en) | 2010-12-31 | 2019-04-24 | Abbott Laboratories | Methods of using human milk oligosaccharides for improving airway respiratory health |
| MX352677B (es) | 2011-06-20 | 2017-12-04 | Heinz Co Brands H J Llc | Composiciones probioticas y metodos. |
| ITUD20120064A1 (it) * | 2012-04-17 | 2013-10-18 | Biofarma S P A | Prodotto confezionato comprendente un integratore alimentare per l'infanzia |
| DK3351554T3 (da) | 2012-06-18 | 2021-08-30 | Heinz Co Brands H J Llc | Glutenrelaterede forstyrrelser |
| PT2994150T (pt) * | 2013-05-10 | 2019-06-14 | Heinz Co Brands H J Llc | Probióticos e métodos de utilização |
| MX2017007969A (es) * | 2015-01-16 | 2018-04-10 | Biogaia Ab | Bacterias de acido lactico y su uso para el tratamiento de mastitis. |
| CN110302214A (zh) * | 2019-08-21 | 2019-10-08 | 中国人民解放军总医院 | 一种乳酸菌联合中链甘油三酯在修复肠道炎症中的应用 |
| WO2021144466A1 (en) * | 2020-01-16 | 2021-07-22 | Société des Produits Nestlé S.A. | Compositions and methods for the treatment of mastitis |
| US20230241134A1 (en) | 2020-06-30 | 2023-08-03 | Biogaia Ab | Probiotic composition for topical use |
| WO2024081219A1 (en) | 2022-10-14 | 2024-04-18 | Csp Technologies, Inc. | Container and method for storing and stabilizing moisture sensitive products |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT275040B (de) * | 1967-04-11 | 1969-10-10 | Werner Buehrdel | Verfahren zur Verlängerung der Lebensfähigkeit und zur Erleichterung der therapeutischen Applizierbarkeit gefriergetrockneter Bakterienkulturen |
| US4518696A (en) * | 1983-01-11 | 1985-05-21 | Chr. Hansen's Laboratory, Inc. | Stabilized liquid bacterial suspension for oral administration to animals |
| US4591499A (en) * | 1984-01-20 | 1986-05-27 | J. B. Lima, Inc. | Method for treatment and prevention of mastitis |
| US5413960A (en) | 1987-05-01 | 1995-05-09 | Biogaia Ab | Antibiotic reuterin |
| US5458875A (en) | 1990-06-15 | 1995-10-17 | Biogaia Ab | In ovo method for delivering Lactobacillus reuteri to the gastrointestinal tract of poultry |
| RU2021807C1 (ru) * | 1990-08-21 | 1994-10-30 | Муховиков Владимир Васильевич | Способ получения масляной суспензии биопрепаратов |
| CA2127392C (en) * | 1993-07-08 | 2008-05-27 | Hideki Sunohara | Process for producing capsule and capsule obtained thereby |
| US5534253A (en) | 1995-06-07 | 1996-07-09 | Biogaia Ab | Method of treating enteropathogenic bacterial infections in poultry |
| US5837238A (en) | 1996-06-05 | 1998-11-17 | Biogaia Biologics Ab | Treatment of diarrhea |
| AU4059999A (en) * | 1998-06-05 | 1999-12-30 | Wakamoto Pharmaceutical Co., Ltd. | Lactic acid bacterium-containing compositions, drugs and foods |
| ES2317699T3 (es) * | 1998-07-14 | 2009-04-16 | Altea Therapeutics Corporation | Eliminacion controlada de una membrana biologica mediante una carga pirotecnica para un transporte transmembranico. |
| CA2354054C (en) * | 1998-12-11 | 2011-04-12 | Urex Biotech, Inc. | Oral administration of lactobacillus for the treatment and prevention of urogenital infection |
| US6214351B1 (en) * | 1999-08-27 | 2001-04-10 | Morinda, Inc. | Morinda citrifolia oil |
| AUPQ415899A0 (en) | 1999-11-19 | 1999-12-16 | Vasse Research Institute Pty Ltd | Compositions for and methods of treatment of allergic diseases |
| FI110668B (fi) | 2000-06-20 | 2003-03-14 | Aboatech Ab Oy | Probioottien käyttö atooppisten sairauksien primaariseen ehkäisyyn |
| EP1239032A1 (en) | 2001-03-02 | 2002-09-11 | Société des Produits Nestlé S.A. | Lactic acid bacteria as agents for treating and preventing allergy |
| NZ537706A (en) * | 2002-06-28 | 2008-03-28 | Puleva Biotech Sa | Probiotic microbial strains, comprising non-pathogenic strains which are capable of surviving in and being transferred to breast milk and/or amniotic fluid after oral intake in healthy individuals without colonizing other internal organs except mucousas |
| CA2503510C (en) * | 2002-09-26 | 2014-12-02 | Probiohealth, Llc | Prebiotic and preservative uses of oil-emulsified probiotic encapsulations |
| CN1486703A (zh) * | 2002-10-01 | 2004-04-07 | 张希跃 | 哈士蟆油冻干胶囊的制备方法 |
| US7105336B2 (en) * | 2002-10-07 | 2006-09-12 | Biogaia Ab | Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter |
| ES2329020T3 (es) * | 2002-10-18 | 2009-11-20 | Biogaia Ab | Procedimiento para potenciar la funcion inmunitaria en mamiferos usando cepas de lactobacillus reuteri. |
-
2004
- 2004-06-03 US US10/860,201 patent/US7955834B2/en not_active Expired - Fee Related
-
2005
- 2005-05-30 DK DK16165460.3T patent/DK3061458T3/en active
- 2005-05-30 CN CN2011102288880A patent/CN102334561A/zh active Pending
- 2005-05-30 ES ES16165460.3T patent/ES2639827T3/es active Active
- 2005-05-30 SG SG200900212-2A patent/SG149826A1/en unknown
- 2005-05-30 KR KR1020087006629A patent/KR20080034212A/ko not_active Application Discontinuation
- 2005-05-30 CA CA2560472A patent/CA2560472C/en not_active Expired - Fee Related
- 2005-05-30 CA CA2709865A patent/CA2709865C/en active Active
- 2005-05-30 CN CN201510808239.6A patent/CN105456299A/zh active Pending
- 2005-05-30 SI SI200532170T patent/SI3061458T1/sl unknown
- 2005-05-30 WO PCT/SE2005/000806 patent/WO2005117532A2/en active Application Filing
- 2005-05-30 EP EP20080164035 patent/EP1994936A1/en not_active Ceased
- 2005-05-30 NZ NZ550527A patent/NZ550527A/en not_active IP Right Cessation
- 2005-05-30 BR BRPI0510198-0A patent/BRPI0510198A/pt not_active Application Discontinuation
- 2005-05-30 RU RU2006146679/13A patent/RU2385730C2/ru not_active IP Right Cessation
- 2005-05-30 EP EP16165460.3A patent/EP3061458B1/en not_active Not-in-force
- 2005-05-30 KR KR1020097005987A patent/KR20090038493A/ko not_active Application Discontinuation
- 2005-05-30 AU AU2005249338A patent/AU2005249338B2/en not_active Ceased
- 2005-05-30 EP EP05747481.9A patent/EP1758604B1/en not_active Not-in-force
- 2005-05-30 NZ NZ569764A patent/NZ569764A/en not_active IP Right Cessation
- 2005-05-30 CN CN2005800116153A patent/CN1942197B/zh not_active Expired - Fee Related
- 2005-05-30 LT LTEP16165460.3T patent/LT3061458T/lt unknown
-
2006
- 2006-10-17 IL IL178686A patent/IL178686A/en active IP Right Grant
- 2006-10-26 ZA ZA2006/08914A patent/ZA200608914B/en unknown
-
2007
- 2007-01-02 NO NO20070026A patent/NO341456B1/no not_active IP Right Cessation
- 2007-05-30 HK HK07105739.8A patent/HK1100508A1/xx not_active IP Right Cessation
- 2007-12-07 ZA ZA200710691A patent/ZA200710691B/en unknown
-
2008
- 2008-09-16 AU AU2008220929A patent/AU2008220929B2/en not_active Ceased
-
2009
- 2009-11-05 US US12/590,313 patent/US8114397B2/en not_active Expired - Fee Related
-
2011
- 2011-12-06 IL IL216793A patent/IL216793A/en active IP Right Grant
-
2016
- 2016-05-25 HK HK16105944.8A patent/HK1217914A1/zh unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG149826A1 (en) | Method for improved breast milk feeding to reduce the risk of allergy | |
| MX2011007930A (es) | Conjugados de insulina cristalina. | |
| EP2464724A4 (en) | COMPOSITIONS AND METHODS FOR IMPLANTATION OF TREATED ADIPOSE TISSUE AND TREATED ADIPOSE TISSUE PRODUCTS | |
| EP1948307A4 (en) | REDUCING COMPLAINTS CAUSED BY ELECTRICAL STIMULATION | |
| TW200617019A (en) | A process for the preparation of 7α-alkylated 19-norsteroids | |
| GEP20156221B (en) | Agomelatine hydrohalide complex and preparation method thereof | |
| TW200728310A (en) | Process for the preparation of ferri-succinylcasein | |
| SG139621A1 (en) | Thermal treatment for bonding interface stabilization | |
| MX2010006081A (es) | Una bebida saludable y un metodo para mejorar la estabilidad de una bebida. | |
| NZ609501A (en) | Antibodies to notum pectinacetylesterase | |
| HK1124842A1 (en) | Methods of preparing imidazole-based compounds | |
| UA103468C2 (ru) | Соединения циклоалкилокси- и гетероциклоалкилоксипиридина как модуляторы гистаминового рецептора н3 | |
| SG142306A1 (en) | Methods for neuroprotection | |
| EP1943910A4 (en) | BREASTFEEDING PAD | |
| IN2012DN01929A (sl) | ||
| TW200833751A (en) | Method for preparing polyester nanocomposites | |
| UA96574C2 (ru) | Использование ивабрадина для получения лекарств, предназначенных для лечения эндотелиальной дисфункции | |
| SG158857A1 (en) | Preparation of ketone amides | |
| MX2007006368A (es) | Metodos de preparacion de aripiprazol anhidro forma ii. | |
| ZA200705490B (en) | Substituted benzimidazoles for treatment of histomoniasis | |
| EP1729712A4 (en) | METHOD FOR ENHANCING BREAST | |
| PL381051A1 (pl) | Sposób stymulacji dojrzewania loszek | |
| SG148904A1 (en) | Method for human body treatment | |
| PL363712A1 (en) | Method for manufacture of preparation designed to eliminate breast tumour | |
| HK1058357A1 (en) | An improved process for the preparation of secnidazole |